Women diagnosed with early-stage breast cancer often can choose to have a lumpectomy, which removes only cancerous tissue and a thin margin of surrounding healthy cells instead of the entire breast. Current cancer guidelines ...
Sep 16, 2022
0
88
While chemotherapy drugs can be lifesaving, they don't work for all patients or for all cancers. But a team of UTM researchers is looking at new ways to use special types of light to target cancer cells resistant to current ...
Sep 14, 2022
0
85
Tumors have significant differences depending on the person affected, even if they are the same cancer, such as breast cancer. Therefore, precision oncology targets specific genetic characteristics of a tumor and incorporates ...
Sep 1, 2022
0
4
Breast cancer is categorized into three major subtypes: hormone receptor-positive, HER2-positive, and triple-negative. Although there are targeted therapeutic approaches for the first two, there are limited options for triple ...
Aug 29, 2022
0
37
The environment in which breast cancer arises—the interplay between the patient's BMI, tumor size and cancer-specific proteins—is of importance for the prognosis. This is shown in a study from Lund University in Sweden. ...
Aug 25, 2022
0
4
A change in function in a mitochondrial antioxidant protein increases stem cell gene expression that promotes the development of more aggressive cancerous cells, according to a recent Northwestern Medicine study published ...
Aug 24, 2022
0
892
Collagen type XII plays a key role in regulating the organization of the tumor matrix, reveals a new study from the Garvan Institute of Medical Research. A team of scientists led by Associate Professor Thomas Cox, Head of ...
Aug 10, 2022
0
88
A research team at the University of Oklahoma published a study in the journal Advanced Science that presents a new approach to triggering an adaptive immune response.
Aug 9, 2022
0
34
The U.S. Food and Drug Administration has approved Enhertu (am-trastuzumab-deruxtecan-nxki), an intravenous infusion treatment for patients with unresectable or metastatic human epidermal growth factor receptor 2 (HER2)-low ...
Aug 9, 2022
0
20
University of Toronto researchers have designed a new way to grow cells in a lab that enables them to better emulate cancerous tumors. The platform—based on a type of material known as a hydrogel, a soft jelly-like substance—opens ...
Aug 1, 2022
0
69
